Journal
JOURNAL OF NUCLEAR MEDICINE
Volume 59, Issue 4, Pages 603-609Publisher
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.117.196709
Keywords
MRSI; F-18-FET; PET; glioma; congruency
Funding
- International Fellow Award from the Helmholtz Association
- National Institutes of Health [R01EB016064]
Ask authors/readers for more resources
PET imaging of amino acid transport using O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) and proton MR spectroscopy (MRS) imaging of cell turnover measured by the ratio of choline to N-acetyl-aspartate (Cho/NAA) may provide additional information on tumor extent of cerebral gliomas compared with anatomic imaging; however, comparative studies are rare. Methods: In this prospective study, 41 patients (16 women, 25 men; mean age +/- SD, 48 +/- 14 y) with cerebral gliomas (World Health Organization [WHO] grade II: 10 [including 1 patient with 2 lesions], WHO III: 17, WHO IV: 13, without biopsy low-grade: 1, high-grade: 1) were investigated with a hybrid PET/MR scanner. Tumor extent, spatial overlap, and the distance between the corresponding centers of mass in F-18-FET PET and MRS imaging of Cho/NAA, determined by simultaneously acquired, 3-dimensional spatially resolved MRS imaging data, were compared. Results: The average tumor volumes for F-18-FET uptake and increased Cho/NAA were 19 +/- 20 cm(3) (mean +/- SD) and 22 +/- 24 cm(3), respectively, with an overlap of 40% +/- 25% and separation of the centers of mass by 9 +/- 8 mm. None of the parameters showed a significant correlation with tumor grade. Conclusion: F-18-FET uptake and increased Cho/NAA ratio are not always congruent and may represent different properties of glioma metabolism. The relationship to histologic tumor extent needs to be further analyzed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available